Report copyright - Progenics - stockholderdocs.com Rebuttal Deck (June 20th… · – 1095: Phase 2 interim analysis may support rapid advancement into Phase 3 Stock outperforms comparable oncology
Please pass captcha verification before submit form
Please pass captcha verification before submit form